Imunon, Inc. Current Assets
Imunon, Inc. (IMNN) had Current Assets of $8.69 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $8.69M.
- 2026-03-31: Assets, Current $6.62M.
- 2025-12-31: Assets, Current $10.72M.
- 2025-09-30: Assets, Current $7.26M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.69M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $6.62M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $10.72M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $7.26M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.89M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $5.09M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $8.01M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $12.53M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $7.65M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $12.09M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $18.24M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $21.73M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $26.73M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $36.33M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $36.78M 10-K · filed 2024-03-28 | $37.15M 10-K · filed 2023-03-30 |
| 2022-09-30 | $40.19M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $44.91M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $43.87M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $51.95M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $56.76M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $60.31M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $56.25M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $18.82M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $19.91M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $26.80M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $18.88M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $16.24M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $20.11M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $23.05M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $24.86M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $28.13M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $22.25M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $26.34M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $20.85M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $24.31M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $2.77M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $3.74M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $4.61M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $4.51M 10-K · filed 2018-03-27 | |
| 2016-09-30 | $9.03M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $14.97M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $14.68M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $20.28M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $24.78M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $31.47M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $30.67M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $37.51M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $44.50M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $50.55M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $52.82M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $43.76M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $46.10M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $49.57M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $46.41M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $23.65M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $23.77M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $24.93M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $25.77M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $31.51M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $22.21M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $6.21M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $2.03M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |